{"success":true,"data":{"pressRelease":{"id":"135042","rtpr_id":"nGNX9Lx9fR","ticker":"TECX","exchange":"NASDAQ","all_tickers":["TECX"],"title":"Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference","author":"Globe Newswire","published_at":"2026-09-03T12:00:00.977Z","article_body":"WATERTOWN, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic,\nInc.\n(https://www.globenewswire.com/Tracker?data=hsvhVzKzi5hFdmfz7uABnhZLY2OWaI3ftLzZeltyu9RkTWStokJv4HcaJWT55tx7QWrrL_BGJ96UdGle3t9Heumh__oBy3JyLDjbj3J47Nk=)\n(NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company\nfocused on the discovery and development of therapeutic proteins and\nantibodies that modulate the activity of G-protein coupled receptors (GPCRs),\ntoday announced that Alise Reicin, MD, President and Chief Executive Officer,\nwill participate in a fireside chat at the upcoming Morgan Stanley 24th Annual\nGlobal Healthcare Conference.\n\nMorgan Stanley 24th Annual Global Healthcare Conference\n\n Date:       September 14, 2026                                                                         \n Time:       5:35 PM ET                                                                                 \n Location:   New York, NY                                                                               \n Format:     Fireside Chat                                                                              \n Presenter:  Alise Reicin, MD, President and Chief Executive Officer                                    \n Webcast:    Link (https://event.webcasts.com/starthere.jsp?ei=1774693&tp_key=49d6b0b0e4&tp_special=8)  \n                                                                                                        \n\nThe live fireside chat can also be accessed under “Events & Presentations\n(https://www.globenewswire.com/Tracker?data=TvjCK_-Cz2O2eKE65UX7P1umoFQkb_AJkolBkc7YYbCoNRkkPimqPeGOGjlWi7iADE6sqBisrSv_ZpbHTGvXx7KKslqZbm50d7mzBCyd3vBcMhC4uCvlf3OGyaYcSlRH3KkQ_I-zbN4nOwv_Lrl_gauUDG4yPLrNMTE9iT0S_u4=)”\non the Investors section of the Tectonic website at www.tectonictx.com. Once\nthe live event has concluded, a replay of the event will be available on the\nCompany’s website for approximately 90 days.\n\nThe Tectonic management team will host one-on-one meetings during the\nconference. Interested investors should contact their Morgan Stanley\nrepresentative to schedule meetings.\n\nAbout Tectonic\nTectonic Therapeutic\n(https://www.globenewswire.com/Tracker?data=hsvhVzKzi5hFdmfz7uABnng0HOT9fEvKSSRVnGuwn3nupPlR2sAIkWGWT-GRJkUOfZAJQQ4lGgRu-927l-g9bV2Y-aKYuFMxQuYQOX-xaYw=) is\na clinical-stage biotechnology company focused on the discovery and\ndevelopment of therapeutic proteins and antibodies that modulate the activity\nof GPCRs. Leveraging its proprietary technology platform called GEODe™\n(GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing\nbiologic medicines that overcome the existing challenges of GPCR-targeted drug\ndiscovery and harness the human body to modify the course of disease. Tectonic\nfocuses on areas of significant unmet medical need, often where therapeutic\noptions are poor or nonexistent, as these are areas where new medicines have\nthe potential to improve patient quality of life. Tectonic is headquartered\nin Watertown, Massachusetts. For more information, please visit\nwww.tectonictx.com and follow us on LinkedIn\n(https://www.globenewswire.com/Tracker?data=W9059ItKkZNWPTKZQgwQ6J9wIvR420gyE_PKkSdIAkaxs2JOfPrsvKp-PbIPLU9m-jq8O6IZe9cFZUnJ7EDo0GNIlTB2hSc3gTw1wGw765Q=).\n\nContacts:\n\nInvestors:\nDan Ferry\nLifeSci Advisors\n(617) 430-7576\ndaniel@lifesciadvisors.com\n\nMedia:\nKathryn Morris\nThe Yates Network\n(914) 204-6412\nkathryn@theyatesnetwork.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/7c13d2a1-2971-4ab0-a4b5-608923316546)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX9Lx9fR","title":"Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference","author":"Globe Newswire","ticker":"TECX","created":"2026-09-03T12:00:00.977Z","tickers":["TECX"],"exchange":"NASDAQ","article_body":"WATERTOWN, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic,\nInc.\n(https://www.globenewswire.com/Tracker?data=hsvhVzKzi5hFdmfz7uABnhZLY2OWaI3ftLzZeltyu9RkTWStokJv4HcaJWT55tx7QWrrL_BGJ96UdGle3t9Heumh__oBy3JyLDjbj3J47Nk=)\n(NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company\nfocused on the discovery and development of therapeutic proteins and\nantibodies that modulate the activity of G-protein coupled receptors (GPCRs),\ntoday announced that Alise Reicin, MD, President and Chief Executive Officer,\nwill participate in a fireside chat at the upcoming Morgan Stanley 24th Annual\nGlobal Healthcare Conference.\n\nMorgan Stanley 24th Annual Global Healthcare Conference\n\n Date:       September 14, 2026                                                                         \n Time:       5:35 PM ET                                                                                 \n Location:   New York, NY                                                                               \n Format:     Fireside Chat                                                                              \n Presenter:  Alise Reicin, MD, President and Chief Executive Officer                                    \n Webcast:    Link (https://event.webcasts.com/starthere.jsp?ei=1774693&tp_key=49d6b0b0e4&tp_special=8)  \n                                                                                                        \n\nThe live fireside chat can also be accessed under “Events & Presentations\n(https://www.globenewswire.com/Tracker?data=TvjCK_-Cz2O2eKE65UX7P1umoFQkb_AJkolBkc7YYbCoNRkkPimqPeGOGjlWi7iADE6sqBisrSv_ZpbHTGvXx7KKslqZbm50d7mzBCyd3vBcMhC4uCvlf3OGyaYcSlRH3KkQ_I-zbN4nOwv_Lrl_gauUDG4yPLrNMTE9iT0S_u4=)”\non the Investors section of the Tectonic website at www.tectonictx.com. Once\nthe live event has concluded, a replay of the event will be available on the\nCompany’s website for approximately 90 days.\n\nThe Tectonic management team will host one-on-one meetings during the\nconference. Interested investors should contact their Morgan Stanley\nrepresentative to schedule meetings.\n\nAbout Tectonic\nTectonic Therapeutic\n(https://www.globenewswire.com/Tracker?data=hsvhVzKzi5hFdmfz7uABnng0HOT9fEvKSSRVnGuwn3nupPlR2sAIkWGWT-GRJkUOfZAJQQ4lGgRu-927l-g9bV2Y-aKYuFMxQuYQOX-xaYw=) is\na clinical-stage biotechnology company focused on the discovery and\ndevelopment of therapeutic proteins and antibodies that modulate the activity\nof GPCRs. Leveraging its proprietary technology platform called GEODe™\n(GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing\nbiologic medicines that overcome the existing challenges of GPCR-targeted drug\ndiscovery and harness the human body to modify the course of disease. Tectonic\nfocuses on areas of significant unmet medical need, often where therapeutic\noptions are poor or nonexistent, as these are areas where new medicines have\nthe potential to improve patient quality of life. Tectonic is headquartered\nin Watertown, Massachusetts. For more information, please visit\nwww.tectonictx.com and follow us on LinkedIn\n(https://www.globenewswire.com/Tracker?data=W9059ItKkZNWPTKZQgwQ6J9wIvR420gyE_PKkSdIAkaxs2JOfPrsvKp-PbIPLU9m-jq8O6IZe9cFZUnJ7EDo0GNIlTB2hSc3gTw1wGw765Q=).\n\nContacts:\n\nInvestors:\nDan Ferry\nLifeSci Advisors\n(617) 430-7576\ndaniel@lifesciadvisors.com\n\nMedia:\nKathryn Morris\nThe Yates Network\n(914) 204-6412\nkathryn@theyatesnetwork.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/7c13d2a1-2971-4ab0-a4b5-608923316546)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-09-03T12:00:01.162926558Z","server_sent_at_ms":1788436801162},"received_at":"2026-09-03T12:00:01.221Z","source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355846/0/en/tectonic-therapeutic-to-participate-in-the-morgan-stanley-global-healthcare-conference.html"},"analysis":{"id":"123925","press_release_id":"135042","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Tectonic Therapeutic (NASDAQ: TECX) announced that CEO Alise Reicin, MD, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026 at 5:35 PM ET in New York.\n\nThe fireside chat will be webcast live, with a replay available on the company's website for approximately 90 days, and management will host one-on-one meetings arranged through Morgan Stanley representatives.\n\nNo new clinical, financial, or business information was included; this is a routine investor-conference calendar announcement for the clinical-stage GPCR-focused biotech.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference participation announcement with no new data -- suppress or log as calendar item only."},"keyFigures":{},"namedEntities":{"people":[{"name":"Alise Reicin, MD","role":"President and Chief Executive Officer"},{"name":"Dan Ferry","role":"Investor relations contact, LifeSci Advisors"},{"name":"Kathryn Morris","role":"Media contact, The Yates Network"}],"products":["GEODe™ (GPCRs Engineered for Optimal Discovery)"],"companies":[{"name":"Tectonic Therapeutic, Inc.","ticker":"TECX","relationship":"filer"},{"name":"Morgan Stanley","relationship":"conference host"},{"name":"LifeSci Advisors","relationship":"investor relations firm"},{"name":"The Yates Network","relationship":"media relations firm"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine investor-relations announcement of conference participation with no new clinical, financial, or strategic information disclosed. Boilerplate calendar item for a clinical-stage biotech."},"tickerRelevance":{"others":[],"primary":"TECX"},"globalImportance":5,"audienceRelevance":12,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap clinical-stage biotech","eventGravity":"conference-participation","issuerAuthored":true,"routineCalendarItem":true,"newInformationDisclosed":false}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Tectonic Therapeutic (NASDAQ: TECX) announced that CEO Alise Reicin, MD, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026 at 5:35 PM ET in New York.\n\nThe fireside chat will be webcast live, with a replay available on the company's website for approximately 90 days, and management will host one-on-one meetings arranged through Morgan Stanley representatives.\n\nNo new clinical, financial, or business information was included; this is a routine investor-conference calendar announcement for the clinical-stage GPCR-focused biotech.","key_figures":{},"named_entities":{"people":[{"name":"Alise Reicin, MD","role":"President and Chief Executive Officer"},{"name":"Dan Ferry","role":"Investor relations contact, LifeSci Advisors"},{"name":"Kathryn Morris","role":"Media contact, The Yates Network"}],"products":["GEODe™ (GPCRs Engineered for Optimal Discovery)"],"companies":[{"name":"Tectonic Therapeutic, Inc.","ticker":"TECX","relationship":"filer"},{"name":"Morgan Stanley","relationship":"conference host"},{"name":"LifeSci Advisors","relationship":"investor relations firm"},{"name":"The Yates Network","relationship":"media relations firm"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-03T12:11:12.143Z","global_importance":5,"audience_relevance":12,"importance_components":{"tickerTier":"small-cap clinical-stage biotech","eventGravity":"conference-participation","issuerAuthored":true,"routineCalendarItem":true,"newInformationDisclosed":false}},"durationMs":null,"modelName":"glm-4.7"}}